Literature DB >> 8116083

Prolonged stabilization of multiple and single brain metastases from breast cancer with tamoxifen. Report of three cases.

M Salvati1, L Cervoni, G Innocenzi, L Bardella.   

Abstract

Cancer frequently metastasizes to the brain, and such lesions, whether multiple or solitary, have a poor prognosis, despite all efforts to treat them. There have been recent sporadic reports of brain metastases from breast cancer responding for some years to antiestrogens (particularly tamoxifen) or bromocriptine. We report three cases of brain metastasis from cancer--two multiple and one a solitary lesion. The long survival of the patients--two for 5 years and one for 6 years, with more than an acceptable quality of life - should prompt therapeutic trials to test tamoxifen and designed to assess its effects on a sizable number of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8116083     DOI: 10.1177/030089169307900516

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  12 in total

Review 1.  Treatment of brain metastases: chemotherapy.

Authors:  Sean A Grimm
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

Review 2.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

3.  [The observation of edema in the substantia alba during postoperative brain irradiation. The role of computed tomographic studies].

Authors:  U Thalacker; G Liszka; A Somogyi; G Németh
Journal:  Strahlenther Onkol       Date:  1998-01       Impact factor: 3.621

Review 4.  Systemic therapy for brain metastases.

Authors:  Jonathan W Rick; Maryam Shahin; Ankush Chandra; Cecilia Dalle Ore; John K Yue; Alan Nguyen; Garima Yagnik; Soumya Sagar; Saman Arfaie; Manish K Aghi
Journal:  Crit Rev Oncol Hematol       Date:  2019-07-22       Impact factor: 6.312

Review 5.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.

Authors:  Marc C Chamberlain; Christina S Baik; Vijayakrishna K Gadi; Shailender Bhatia; Laura Q M Chow
Journal:  Neuro Oncol       Date:  2017-01       Impact factor: 12.300

6.  Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader.

Authors:  Suzanne E Wardell; Erik R Nelson; Christina A Chao; Holly M Alley; Donald P McDonnell
Journal:  Endocr Relat Cancer       Date:  2015-07-10       Impact factor: 5.678

Review 7.  The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer.

Authors:  Shyam Tanguturi; Laura E G Warren
Journal:  Curr Oncol Rep       Date:  2019-04-16       Impact factor: 5.075

8.  Brain metastases from breast cancer may respond to endocrine therapy: report of two cases.

Authors:  Qian Wang; Bing Sun; Chao Liu; Sanzhong Shi; Lijuan Ding; Jiannan Liu; Shikai Wu
Journal:  Onco Targets Ther       Date:  2019-02-19       Impact factor: 4.147

9.  Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions.

Authors:  Shih-Ying Wu; Sambad Sharma; Kerui Wu; Abhishek Tyagi; Dan Zhao; Ravindra Pramod Deshpande; Kounosuke Watabe
Journal:  Breast Cancer Res       Date:  2021-03-18       Impact factor: 6.466

10.  Breast cancer brain metastases: new directions in systemic therapy.

Authors:  Nancy U Lin
Journal:  Ecancermedicalscience       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.